Atlas Trials

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Clinical trial NCT00626158 · COMPLETED

Trial details

NCT number
NCT00626158
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic CancerBiliary Cancer
Start date
2008-02-01
Primary completion
2010-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.